Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2003
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337633A2 Anti-angiogenic proteins and fragments and methods of use thereof
08/27/2003EP1337632A2 Differentiated cells suitable for human therapy
08/27/2003EP1337630A2 Modified arginine deiminase
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337556A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof
08/27/2003EP1337551A1 Substance p analogs for the treatment of cancer
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337525A1 Process for the crystallization of (r)- or (s)-lansoprazole
08/27/2003EP1337524A1 Substituted quinolines as antitumor agents
08/27/2003EP1337522A1 0ovel farnesyl protein transferase inhibitors
08/27/2003EP1337521A1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
08/27/2003EP1337513A1 4-substituted quinolines as antitumor agents
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1337504A2 Novel polyamine analog-amino acid conjugates useful as anticancer agents
08/27/2003EP1337285A1 Implants with a phosphazene-containing coating
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337277A1 Radio-labelled ferrite particles and methods for the manufacture and use thereof
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337275A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
08/27/2003EP1337273A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337259A2 Methylenetetrahydrofolate reductase inhibitors and use thereof
08/27/2003EP1337258A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof
08/27/2003EP1337256A2 Use of thienopyrimidines
08/27/2003EP1337234A1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling
08/27/2003EP1337233A1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling
08/27/2003EP1337152A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
08/27/2003EP1337149A2 Vaccine immunotherapy for immune suppressed patients
08/27/2003EP1185540B1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
08/27/2003EP1183047B1 Pharmaceutical preparation
08/27/2003EP1181046B1 10-formyltetrahydrofolate dehydrogenase as therapeutical agent
08/27/2003EP1143920B1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
08/27/2003EP1140944B1 Epothilone derivatives and their use as antitumor agents
08/27/2003EP1140938B1 High affinity inhibitors for target validation and uses thereof
08/27/2003EP1140889B1 Compounds and methods for modulation of estrogen receptors
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1095039B1 New pharmaceutically active compounds
08/27/2003EP1070057B1 Use of 7-acyltaxols for the treatment of multidrug resistant cells
08/27/2003EP1033972B1 Drug delivery system with two-step targeting
08/27/2003EP1021178B1 Selenophene anti-tumor agents
08/27/2003EP1011687A4 13-deoxyanthracycline derivatives and processes for preparing them
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0946567B1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
08/27/2003EP0909277B1 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/27/2003CN1439056A Herpes viruses for immune modulation
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439020A Biosynthetic oncolytic molecules and uses therefor
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439006A Novel compounds possessing antibacterial, antifungal or antitumor activity
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438994A Polymorphic forms/hydrates of N-[4-(3-chloro-4-fluoro-phenylamino)-7- (3-morpholin-4-ylpropoxy)-quinazolin-6-Yl] acrylamide dihydrochloride
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438893A Therapeutical use of sophora flavescens or sophora subprostrated extracts
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438884A Therapeutic combinations of fatty acids
08/27/2003CN1438882A Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
08/27/2003CN1438877A Prolonged release micro spheres for injection delivery and preparation method
08/27/2003CN1438322A Method for diagnosis and treatment of hair eipidermal tumor using human's CYLD gene and its coded products
08/27/2003CN1438313A Method for preparing microcapsulized functional cell
08/27/2003CN1438037A Supersonic contrast medium and supersonic contrast medium simultaneously as medicine and gene target carrier
08/27/2003CN1438030A Method for preparing tumor specific transfer factors
08/27/2003CN1437996A Huanyang blood-changing pill and its preparation method
08/27/2003CN1437986A Liver-relieving kidney-nourishing liquid
08/27/2003CN1437978A Chinese medicine for gynaecological tumor and preparation method
08/27/2003CN1437977A Medicine for treating lung cancer
08/27/2003CN1437961A Chinese medicine for resisting cancer and treating cancer
08/27/2003CN1437956A Five-poison chicken for preventing and treating cancer and preparation method
08/27/2003CN1437951A Anti-tumor function of sophorine and its medicine preparation
08/27/2003CN1437942A Vinorebin powder injection and preparation method
08/27/2003CN1437884A Food for preventing and treating cancer and preparation method thereof
08/27/2003CN1119416C Human interleukin 2 derivatives and human heart sodium medium fusion gene, its protein products and uts thereof
08/27/2003CN1119415C Clone and expression of anti-CA125 bifunctional genetically engineered antibody
08/27/2003CN1119351C Cyclic adhesion inhibitors
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119345C Benzo (5,6) cycloheptapyridine compounds use furl as farnesyl protein transferase inhibitors
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119334C Substsituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of disease charaterized by abnomal cell proliferation
08/27/2003CN1119313C Inhibition of matrix metallo proteases by 2-(omega-aroylalkyc)-4-biaryl-oxobutyric acids
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/27/2003CN1119163C Anticancer medicine composition
08/27/2003CN1119153C Injection for treating tumor in respiratory system and its appliation
08/27/2003CN1119152C Injection for treating tumor in digestive system and its application
08/27/2003CN1119149C 10,11 methanodibenzosuberane derivatives used as chemo sensitizing agents
08/27/2003CN1119146C Compositions and kits for increasing the oral bioavailability of pharmaceutical agents
08/27/2003CN1119080C Implantable agarose-collagen beads containing cells which produce a diffusible bilogical product, and uses thereof
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610860 C7 ester substituted taxanes
1 ... 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 ... 2211